DK160039B - THE COMPOUND ALFA-BROMIDAETHYL CARBONATE AND USE OF ALFA-BROMIDAETHYL CARBONATE IN THE PREPARATION OF THE AETOXYCARBONYLOXYAETHYL ESTATE OF PENICILLIN G - Google Patents

THE COMPOUND ALFA-BROMIDAETHYL CARBONATE AND USE OF ALFA-BROMIDAETHYL CARBONATE IN THE PREPARATION OF THE AETOXYCARBONYLOXYAETHYL ESTATE OF PENICILLIN G Download PDF

Info

Publication number
DK160039B
DK160039B DK296683A DK296683A DK160039B DK 160039 B DK160039 B DK 160039B DK 296683 A DK296683 A DK 296683A DK 296683 A DK296683 A DK 296683A DK 160039 B DK160039 B DK 160039B
Authority
DK
Denmark
Prior art keywords
carbonate
compound
penicillin
bromide
diethyl carbonate
Prior art date
Application number
DK296683A
Other languages
Danish (da)
Other versions
DK296683D0 (en
DK160039C (en
DK296683A (en
Inventor
Luigi Ratti
Derek Reginald Palmer
Robert Graham Tyson
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT22141/82A external-priority patent/IT1190897B/en
Priority claimed from GB838300331A external-priority patent/GB8300331D0/en
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of DK296683D0 publication Critical patent/DK296683D0/en
Publication of DK296683A publication Critical patent/DK296683A/en
Publication of DK160039B publication Critical patent/DK160039B/en
Application granted granted Critical
Publication of DK160039C publication Critical patent/DK160039C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00Preparation of esters of carbonic or haloformic acids
    • C07C68/02Preparation of esters of carbonic or haloformic acids from phosgene or haloformates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96Esters of carbonic or haloformic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

D K ' Γ u:. V idD K 'Γ u:. V id

Den foreliggende opfindelse angår den hidtil ukendte forbindelse alfa-bromdiætylkarbonat og anvendelse af denne forbindelse som udgangsmateriale ved fremstilling af ætoxy-karbonyloxyætylesteren af penicillin G.The present invention relates to the novel compound alpha-bromo diethyl carbonate and the use of this compound as a starting material in the preparation of the ethoxycarbonyloxyethyl ester of penicillin G.

5 Ætoxykarbonyloxyætylesteren af penicillin G er udgangs materiale ved fremstilling af bacampicillin, en ampicillin-ester som er yderst vigtig fra et terapeutisk synspunkt fordi den absorberes godt ved oral indgift og giver meget højere indhold af ampicillin i blodet end ampicillin selv.5 The ethoxycarbonyloxyethyl ester of penicillin G is the starting material in the preparation of bacampicillin, an ampicillin ester which is extremely important from a therapeutic point of view because it is well absorbed by oral administration and provides much higher levels of ampicillin in the blood than ampicillin itself.

10 Alfa-bromdiætylkarbonat har formlenAlpha-bromo diethyl carbonate has the formula

Br OBr O

I III II

CH_-CH-0-C-0-C„Hc ICH_-CH-0-C-0-C "Hc I

3 2 5 og anvendes med fordel som reaktionskomponent ved forestring 15 af penicillin G. Anvendelse af alfa-bromdiætylkarbonat fører til specielt højt udbytte og høj renhed, også af slutprodukterne såsom bacampicillin.3 2 5 and is advantageously used as the reaction component of esterification 15 of penicillin G. Use of alpha-bromo diethyl carbonate leads to particularly high yield and high purity, also of the end products such as bacampicillin.

Forbindelsen alfa-bromdiætylkarbonat kan fremstilles ved følgende fremgangsmåder: 20 A. Ved reaktion mellem det tilsvarende alfa-klordiætyl-karbonat og natriumbromid. Denne fremgangsmåde er eksemplificeret i omstående eksempel 1 .The compound alpha-bromo diethyl carbonate can be prepared by the following methods: 20 A. By reaction between the corresponding alpha-chloro diethyl carbonate and sodium bromide. This procedure is exemplified in the above Example 1.

B. Ved en flertrinsproces omfattende følgende trin: a) omsætning af et aldehyd med formlen CH^CHO (n) med 25 karbonylbromid med formlen COB^ (III) til dannelse af et a- brom-bromformiat med formlenB. In a multi-step process comprising the following steps: a) reacting an aldehyde of formula CH 2 CHO (n) with carbonyl bromide of formula COB ^ (III) to form an α-bromo bromoformate of formula

Brbr

CH3-CH.O.CO.Br IVCH3-CH.O.CO.Br IV

30 hvorpå man b) omsætter α-brom-bromformiatet med formel IV med en alkohol med formlen C2H5OH til frembringelse af det ønskede α-bromdiætylkarbonat med formel I.30) reacting the α-bromo-bromoformate of formula IV with an alcohol of formula C2H5OH to produce the desired α-bromo diethyl carbonate of formula I.

Proces B ifølge opfindelsen kan således summarisk gen-35 gives ved reaktionsskemaet: 2Process B of the invention can thus be summarized in the reaction scheme: 2

DK 160039 BDK 160039 B

Br +C,H,-OH Br I 2 5 j CH3CHO + COBr2-> CH3-CH.O.CO.Br -->CH3-CH.O.CO.C2H5 + HBr 5 Alfa-brom-bromformiat med formel IV er i sig selv en hidtil ukendt forbindelse.Br + C, H, -OH Br I 2 5 j CH3CHO + COBr2-> CH3-CH.O.CO.Br -> CH3-CH.O.CO.C2H5 + HBr 5 Alpha-bromo-bromoformate of formula IV is itself a novel connection.

Reaktionen mellem aldehydet CH3CHO og karbonylbromid udføres mest hensigtsmæssigt i nærværelse af en katalysator der fx kan være en tertiær amin (såsom en tertiær alifatisk 10 amin, en tertiær blandet alkyl/aryl-amin eller en tertiær aromatisk amin), et tertiært fosfin, et amid, et substitueret urinstof eller tiourinstof, et fosforsyreamid, et tertiært oxonium- eller sulfoniumsalt eller et kvaternært ammoniumeller fosfoniumsalt. Foretrukne eksempler på katalysatorer 15 ved anvendelse i proces A ifølge opfindelsen er bl.a. pyri- din, dimetylformamid, tetra-n-butylurinstof, hexametylfosfor-triamid og benzyltrimetylammoniumbromid.The reaction between the aldehyde CH3CHO and carbonyl bromide is most conveniently carried out in the presence of a catalyst which may be, for example, a tertiary amine (such as a tertiary aliphatic amine, a tertiary mixed alkyl / aryl amine or a tertiary aromatic amine), a tertiary , a substituted urea or thiourea, a phosphoric acid amide, a tertiary oxonium or sulfonium salt or a quaternary ammonium or phosphonium salt. Preferred examples of catalysts 15 for use in process A of the invention include pyridine, dimethylformamide, tetra-n-butylurea, hexamethylphosphoric triamide and benzyltrimethylammonium bromide.

Katalysatoren bruges hensigtsmæssigt i en mængde på fra 0,05 til 0,5, fortrinsvis fra 0,05 til 0,15 mol katalysa-20 tor pr. mol aldehyd.The catalyst is suitably used in an amount of from 0.05 to 0.5, preferably from 0.05 to 0.15 moles of catalyst per minute. moles of aldehyde.

Reaktionen mellem aldehydet og karbonylbromidet udføres hensigtsmæssigt i nærværelse af et opløsningsmiddel der fx kan være en aromatisk kulbrinte såsom toluen eller en halogeneret kulbrinte såsom diklormetan, kulstoftetraklorid eller 25 klorbenzen. Reaktionen mellem aldehydet og karbonylbromidet udføres hensigtsmæssigt ved en temperatur mellem -40 og +120°C, fortrinsvis ved en temperatur på 0-40°C. Karbonylbromidet vil sædvanligvis blive anvendt i molært overskud i forhold til aldehydet, hensigtsmæssigt i et molært overskud på fra 10-100%, 3q fortrinsvis fra 20-50%.The reaction between the aldehyde and the carbonyl bromide is conveniently carried out in the presence of a solvent which may be, for example, an aromatic hydrocarbon such as toluene or a halogenated hydrocarbon such as dichloromethane, carbon tetrachloride or chlorobenzene. The reaction between the aldehyde and the carbonyl bromide is conveniently carried out at a temperature between -40 and + 120 ° C, preferably at a temperature of 0-40 ° C. The carbonyl bromide will usually be used in molar excess relative to the aldehyde, conveniently in a molar excess of from 10-100%, 3q preferably from 20-50%.

Det som mellemprodukt vundne α-brom-bromformiat med formel iv, der fremkommer i trin a) i proces B, behøver ikke at blive isoleret før reaktionen med alkoholen C2H^OH; faktisk foretrækkes det i almindelighed ikke 35 at foretage en sådan isolering. Ifølge en foretrukken udførelsesform for denne reaktion befris den i trin a) vundne reaktionsblanding således for overskydende karbonylbromid, fx ved opvarmning under nedsat tryk eller ved skylning med 3 DK 1ό00οΓ·3 nitrogen. Den rå a-brom-bromformiatholdige reaktionsblanding omsættes derefter med overskud af alkoholen. Reaktionen kan hensigtsmæssigt udføres ved opvarmning af blandingen under tilbagesvaling indtil udviklingen af hydrogenbromid hører op 5 eller ved tilsætning af en tertiær base til blandingen og om nødvendigt opvarmning af den. Eventuelt tilbageværende katalysator fra trin a) eller kompleks af denne med karbonylbromid synes ikke at indgribe i den påfølgende reaktion og forekommer i nogle tilfælde at være gunstig.The intermediate α-bromo-bromoformate of formula IV obtained in step a) of process B need not be isolated prior to the reaction with the alcohol C 2 H 2 OH; in fact, such an insulation is generally not preferred. Thus, according to a preferred embodiment of this reaction, the reaction mixture obtained in step a) is liberated from excess carbonyl bromide, for example by heating under reduced pressure or by rinsing with nitrogen. The crude α-bromo-bromoformate-containing reaction mixture is then reacted with excess alcohol. The reaction may conveniently be carried out by heating the mixture under reflux until the evolution of hydrogen bromide ceases or by adding a tertiary base to the mixture and heating it if necessary. Any residual catalyst from step a) or complex thereof with carbonyl bromide does not appear to interfere with the subsequent reaction and in some cases appears to be favorable.

10 Det resulterende rå α-bromkarbonat kan hensigtsmæssigt isoleres fra reaktionsblandingen ved fraktioneret destillation under nedsat tryk.The resulting crude α-bromocarbonate may conveniently be isolated from the reaction mixture by fractional distillation under reduced pressure.

Proces B belyses ved omstående eksempler 2 og 3.Process B is illustrated by the following Examples 2 and 3.

C. Den anden proces til fremstilling af alfa-bromdiætyl- 15 karbonat vil nu blive beskrevet. Metode C er eksemplificeret i omstående eksempel 4C. The second process for producing alpha-bromo diethyl carbonate will now be described. Method C is exemplified in the above Example 4

Proces C til fremstilling af alfa-bromdiætylkarbonat er en modifikation af Finkelstein-reaktionen, dvs. tilsætning af et alkylklorid eller arylalkylklorid (eller en for-20 bindelse indeholdende en sådan gruppe) med et alkalimetalbro-mid eller alkalimetaljodid til udskiftning af klorsubstituen-ten med henholdsvis en bromsubstituent eller jodsubstituent; eller ved reaktion af et alkylbromid eller arylalkylbromid (eller en forbindelse indeholdende en sådan gruppe) med et 25 alkalimetaljodid til udskiftning af bromsubstituenten med en jodsubstituent.Process C for the preparation of alpha-bromo diethyl carbonate is a modification of the Finkelstein reaction, i.e. adding an alkyl chloride or arylalkyl chloride (or a compound containing such a group) with an alkali metal bromide or alkali metal iodide to replace the chlorine substituent with a bromine or iodine substituent, respectively; or by reaction of an alkyl bromide or arylalkyl bromide (or a compound containing such a group) with an alkali metal iodide to replace the bromine substituent with an iodine substituent.

Ikke alle eventuelt substituerede alkylklorider eller arylalkylklorider undergår reaktionen, og specielt har det vist sig vanskeligt at udføre denne reaktion med alfa-klor-30 estere og alfa-klorkarbonater, dvs. forbindelser hvor kloratomet er bundet til et kulstofatom der for sit vedkommende er knyttet til begge enderne af en gruppe -0(0)-0-. Et eksempel på et sådant alfa-klorkarbonat er alfa-klordiætyl-karbonat, der er et kendt mellemprodukt ved fremstilling af 35 ætoxykarbonyloxyætylestere af 6-aminopenicillansyre og af penicilliner.Not all optionally substituted alkyl chlorides or arylalkyl chlorides undergo the reaction, and in particular it has proved difficult to carry out this reaction with alpha-chloro esters and alpha-chlorocarbonates, ie. compounds wherein the chlorine atom is bonded to a carbon atom which, for its part, is attached to both ends of a group of -0 (0) -0-. An example of such an alpha-chlorocarbonate is alpha-chloro diethyl carbonate, which is a known intermediate in the preparation of 35-ethoxycarbonyloxyethyl esters of 6-aminopenicillanic acid and of penicillins.

Det har nu vist sig at dette problem kan overvindes ved at man går frem i henhold til proces C. Ved denne frem- 4It has now been found that this problem can be overcome by proceeding according to process C. By this progress 4

DK 16 O O ό 9 BDK 16 O O ό 9 B

stilles alfa-bromdiætylkarbonat ved omsætning af alfa-klordiætylkarbonat med et alkalimetalbromid, idet reaktionen udføres i et tofaset opløsningsmiddelsystem indeholdende vand og et vandublandbart organisk opløsningsmiddel og i 5 nærværelse af en faseoverføringskatalysator.alpha-bromo diethyl carbonate is reacted by reaction of alpha-chloro diethyl carbonate with an alkali metal bromide, the reaction being carried out in a two-phase solvent system containing water and a water-immiscible organic solvent and in the presence of a phase transfer catalyst.

Egnede vandublandbare organiske opløsningsmidler til dette formål er bl.a. halogenerede kulbrinter, fx halogenerede paraffiner såsom diklormetan, og aromatiske kulbrinter såsom toluen. Egnede faseoverføringskatalysatorer 10 er bl.a. kvaternære ammoniumsalte, fx tetraalkylammoniumsalte såsom cetyltrimetylammoniumbromid og tetra-n-butylammonium-hydrogensulfat. Alkalimetalbromidet kan fx være natrium-, kalium- eller litiumbromid, idet litiumbromid foretrækkes.Suitable water-immiscible organic solvents for this purpose include halogenated hydrocarbons, e.g., halogenated paraffins such as dichloromethane, and aromatic hydrocarbons such as toluene. Suitable phase transfer catalysts 10 include quaternary ammonium salts, for example tetraalkylammonium salts such as cetyltrimethylammonium bromide and tetra-n-butylammonium hydrogen sulfate. For example, the alkali metal bromide may be sodium, potassium or lithium bromide, with lithium bromide being preferred.

Ved proces B ifølge opfindelsen omsættes således a- 15 klordiætylkarbonat med formlenThus, in process B of the invention, α-chloro diethyl carbonate is reacted with the formula

Cl O I IICl O I II

CH3-CH-0-C-0-C2H5 v i et tofaset opløsningsmiddelsystem, hvor den ene fase er vand 20 °9 den anden et vandublandbart organisk opløsningsmiddel, med et alkalimetalbromid med formlen R-Br (VI) , hvor R er et alkalimetal såsom Na, K eller Li, til dannelse af en forbindelse med formlen 25 f 8 CH3-CH-0-C-0-C2H5 iCH3-CH-O-C-O-C2H5 we a two-phase solvent system, one phase being water 20 ° 9 the other a water-immiscible organic solvent, with an alkali metal bromide of the formula R-Br (VI), wherein R is an alkali metal such as Na, K or Li to form a compound of formula 25 f 8 CH 3 -CH-O-C-O-C 2 H 5 in

Som nævnt ovenfor er det foretrukne alkalimetal R litium, således at det foretrukne reagens med formel VI er LiBr.As mentioned above, the preferred alkali metal is R lithium such that the preferred reagent of formula VI is LiBr.

30 I forbindelse med proces C har det vist sig at litium bromid kan bruges med fordel i en konventionel Finkelstein-reaktion (dvs. en sådan der anvender et enfaset organisk opløsningsmiddelsystem), fx til halogenering af ci-klorkarbonat.In connection with process C, it has been found that lithium bromide can be used advantageously in a conventional Finkelstein reaction (i.e., one using a single-phase organic solvent system), for example, for the halogenation of cichlorocarbonate.

En udførelsesform for metode C består således i at man 35 omsætter alfa-klordiætylkarbonat med litiumbromid, jfr. omstående eksempel 5.Thus, one embodiment of Method C consists of reacting alpha-chloro diethyl carbonate with lithium bromide, cf. about Example 5.

Egnede opløsningsmidler til denne fremgangsmåde er bl.a. lavtkogende alifatiske alkoholer, lavtkogende alifati- 5Suitable solvents for this process include low boiling aliphatic alcohols, low boiling aliphatic 5

DK 100009BDK 100009B

ske ketoner, lavtkogende alifatiske ætere og lavere alifatiske amider af myresyre.ketones, low boiling aliphatic ethers and lower aliphatic amides of formic acid.

Som nævnt angår den foreliggende opfindelse også anvendelse af den beskrevne forbindelse alfa-bromdiætylkarbonat 5 ved fremstilling af ætoxykarbonyloxyætylesteren af penicillin G. Herved omsættes penicillin G eller et salt deraf med alfa-bromdiætylkarbonat til dannelse af ætoxykarbonyloxyætyleste-ren af penicillin G.As mentioned, the present invention also relates to the use of the disclosed compound alpha-bromo diethyl carbonate 5 in the preparation of the ethoxycarbonyloxyethyl ester of penicillin G. Hereby, penicillin G or a salt thereof is reacted with alpha bromo diethyl carbonate to form the ethoxycarbonyloxyethyl ester G.

Der kan anvendes en kvaternær ammoniumforbindelse som 10 katalysator i forestringstrinnet, hvorved den kvaternære ammoniumforbindelse er til stede i en mængde på 1-25%, fortrinsvis 1-10% af den ækvimolære mængde i forhold til mængden af penicillin G. Det er således ikke nødvendigt at anvende en støkiometrisk mængde af den kvaternære ammoniumforbindelse 15 i forhold til mængden af penicillin G, men mindre er tilstrækkeligt.A quaternary ammonium compound can be used as a catalyst in the esterification step, whereby the quaternary ammonium compound is present in an amount of 1-25%, preferably 1-10% of the equimolar amount relative to the amount of penicillin G. It is thus not necessary. to use a stoichiometric amount of the quaternary ammonium compound 15 relative to the amount of penicillin G, but less is sufficient.

Egnede metalsalte af penicillin G til anvendelse i overensstemmelse med dette træk ved opfindelsen (enten som prækursorer for det kvaternære ammoniumsalt af karboxylsyren 20 eller som sådanne) er alkalimetalsalte og jordalkalimetal-salte såsom natrium-, kalium-, litium-, magnium- og kalciumsalte. Egnede kvaternære ammoniumsalte af andre syrer end Denicillin G (til anvendelse enten som prækursorer for de kvaternære ammoniumsalte af penicillin G eller som 25 sådanne) er fx tetraalkylammoniumsalte såsom tetra-n-butyl- ammoniumbromid og cetyltrimetylammoniumbromid samt kvaternære pyridiniumsalte såsom cetylpyridiniumbromid.Suitable metal salts of penicillin G for use in accordance with this feature of the invention (either as precursors of the quaternary ammonium salt of the carboxylic acid 20 or as such) are alkali metal salts and alkaline earth metal salts such as sodium, potassium, lithium, magnesium and calcium salts. Suitable quaternary ammonium salts of acids other than Denicillin G (for use either as precursors for the quaternary ammonium salts of penicillin G or as such) are, for example, tetraalkylammonium salts such as tetra-n-butyl ammonium bromide and cetyltrimethylammonium bromide as well as quaternary pyridinium pyridine bromide

Anvendelsen af alfa-bromdiætylkarbonat ved fremstilling af ætoxykarbonyloxyætylesteren af penicillin G kan ske i nær-30 værelse eller fravær af et opløsningsmiddel. Eksempler på egnede opløsningsmidler er lavtkogende alifatiske alkoholer, lavtkogende alifatiske ketoner, lavtkogende alifatiske amider af myresyre og dimetylsulfoxyd. Hvis der ikke bruges noget særligt opløsningsmiddel kan der også bruges overskud af det 35 esterdannende halogenid, navnlig hvis dette er flydende ved reaktionstemperaturen.The use of alpha-bromo diethyl carbonate in the preparation of the ethoxycarbonyloxyethyl ester of penicillin G can be done in the presence or absence of a solvent. Examples of suitable solvents are low boiling aliphatic alcohols, low boiling aliphatic ketones, low boiling aliphatic amides of formic acid and dimethyl sulfoxide. If no particular solvent is used, excess of the ester-forming halide may also be used, especially if this is liquid at the reaction temperature.

Ved anvendelse af alfa-bromdiætylkarbonat ved fremstil- 6Using alpha-bromo diethyl carbonate in preparation 6

DK 160059BDK 160059B

stilling af ætoxykarbonyloxyætylesteren af penicillin G kan der eventuelt bruges en katalysator. Der kan bruges tilnærmelsesvis ækvimolære mængder af det kvaternære ammoniumsalt af penicillin G og det esterdannende halogenid, dvs. bromdi-5 ætylkarbonatet. Hensigtsmæssigt bruges der mellem 5%s og 100%s overskud af det esterdannende halogenid for hver ækvivalent af det anvendte salt af karboxylsyren, og særlig foretrækkes det at bruge et overskud på mellem 20% og 60% af det esterdannende halogenid.position of the ethoxycarbonyloxyethyl ester of penicillin G, a catalyst may optionally be used. Approximately equimolar amounts of the quaternary ammonium salt of penicillin G and the ester-forming halide can be used, i.e. the bromo diethyl carbonate. Conveniently, between 5% s and 100% s excess of the ester-forming halide is used for each equivalent of the carboxylic acid salt used, and it is especially preferred to use an excess of between 20% and 60% of the ester-forming halide.

10 Det foretrækkes især at bruge tetra-n-butylammonium- bromid som det kvaternære ammoniumsalt.It is particularly preferred to use tetra-n-butylammonium bromide as the quaternary ammonium salt.

Anvendelse af alfa-bromdiætylkarbonat ved fremstilling af ætoxykarbonyloxyætylesteren af penicillin G er eksemplificeret i eksemplerne 7, 8 og 9.The use of alpha-bromo diethyl carbonate in the preparation of the ethoxycarbonyloxyethyl ester of penicillin G is exemplified in Examples 7, 8 and 9.

1515

ForsøgsrapportTrial Reports

Forbindelsen alfa-klordiætylkarbonat, i det følgende betegnet klorforbindelsen, har været anvendt i industriel målestok af bacampicillin fra begyndelsen af kommerciel pro-20 duktion deraf i den første halvdel af 1970erne og frem til 1982. I denne periode optimeredes produktionsmetoden og især forestringen af penicillin G med klorforbindelsen til optimale reaktionsbetingelser.The compound alpha-chloro diethyl carbonate, hereinafter referred to as the chlorine compound, has been used on an industrial scale of bacampicillin from the beginning of its commercial production in the first half of the 1970s up to 1982. During this period the production method and in particular the esterification of penicillin G were optimized. with the chlorine compound for optimal reaction conditions.

I 1982 ændredes den kommercielle produktionsmetode 25 ved at den nævnte klorforbindelse blev erstattet med alfa-bromdiætylkarbonat, i det følgende betegnet bromforbindelsen.In 1982, the commercial production method 25 was changed by replacing said chlorine compound with alpha-bromo diethyl carbonate, hereinafter referred to as the bromine compound.

Ved forsøg på helt sammenlignelig måde med (A) klorforbindelsen anvendt på den ovenfor beskrevne stærkt opti-30 merede metode, og (B) bromforbindelsen på tilsvarende måde opnåedes der følgende resultater:By experimentally comparable to the (A) chlorine compound used in the above-described highly optimized method and (B) the bromine compound in a similar manner, the following results were obtained:

Anvendelse afThe use of

Parameter klorforbindelsen bromforbindelsen 7Parameter chlorine compound bromine compound 7

DK 1(.0069 BDK 1 (.0069 B

5 Udbytte 85% 98-99%Yield 85% 98-99%

Reaktionstid 15 timer 4,5 timerReaction time 15 hours 4.5 hours

Reaktionsblandingernes farve ved afsluttet reaktion sort lysegulThe color of the reaction mixtures at the end of the reaction is black light yellow

Reaktionstemperatur 50°C 40°CReaction temperature 50 ° C 40 ° C

Mængde reaktant (klor- eller 10 bromforbindelse) i forhold til mængde penicillin, mmol 162/125 131/125 I det efterfølgende trin til fremstilling af bacampi-15 cillin-HCl ud fra 1-ætoxykarbonyloxyætylesteren af penicillin G opnåedes ved standard metodik følgende resultater:Amount of reactant (chlorine or bromine compound) relative to amount of penicillin, mmol 162/125 131/125 In the subsequent step of preparing the bacampi-cillin HCl from the 1-ethoxycarbonyloxyethyl ester of penicillin G, the following results were obtained:

Parameter Fremstilling af bacampicillin-HCl ved anvendelse af benzylpenicil-1inætoxykarbonoyloxyæty1ester 20 fremstillet ud fra klorforbindelsen bromforbindelsen 25 Udbytte 48% 77%Parameter Preparation of bacampicillin HCl using benzylpenicil-1-intoxycarbonoyloxyacetyl ester 20 prepared from the chlorine compound bromine compound 25 Yield 48% 77%

Farve i vandig opløsning (absorption ved 405 nm, 5 cm, 2%s opløsning) 0,11 0,01 30 Disse resultater er overraskende. Det kunne ikke for udses at anvendelse af bromforbindelsen ville kunne give ætoxykarbonyloxyæty lesteren af penicillin G i et udbytte på 98-99%, der skal sammenlignes med et udbytte på 85% ud fra klorforbindelsen ved anvendelse af en industrielt optimeret 35 proces. Ejheller kunne den nedsatte reaktionstid forudses, så lidt som det forbedrede udbytte ved fremstilling af slutproduktet bacampicillin-HCl og den forbedrede renhed.Color in aqueous solution (absorption at 405 nm, 5 cm, 2% solution) 0.11 0.01 30 These results are surprising. It could not be foreseen that using the bromine compound could yield the ethoxycarbonyloxyethyl ester of penicillin G in a yield of 98-99%, to be compared with a yield of 85% from the chlorine compound using an industrially optimized process. Also, the reduced reaction time could be predicted as little as the improved yield in the preparation of the final product bacampicillin-HCl and the improved purity.

88

DK 1 60039 BDK 1 60039 B

Et tilsvarende sammenligningsforsøg med alfa-joddiæt-ylkarbonat har ikke kunnet gennemføres fordi denne forbindelse, der bl.a. er kendt fra de europæiske offentliggørelsesskrifter nr 54512 og 34536, ikke er stabil og ikke synes 5 at tåle renfremstilling og opbevaring.A similar comparative experiment with alpha iodine diethyl carbonate could not be carried out because this compound, i. is known from European Publication Nos. 54512 and 34536, is not stable and does not appear to withstand clean production and storage.

Forbindelsen ifølge opfindelsen og dens anvendelse skal i det følgende belyses nærmere ved nogle eksempler.The compound of the invention and its use will be elucidated in the following by some examples.

Eksempel 1 10 ---------- a-Bromdiætylkarbonat acetoneExample 1 10 ---------- a-Bromo diethyl carbonate acetone

NaBr + Cl-<j:H-OCOOC2H5-> Br-CH-OCOOC2H5 + NaCl 15 CH3 CH3 102,9 g natriumbromid opløst i 600 ml aceotne omsattes i 2-3 timer ved stuetemperatur (20-25°C) med 152,6 g a-klor-diætylkarbonat opløst i 100 ml acetone. Derefter koncentrere-20 des blandingen under vakuum ved lav temperatur, højst 35°C, indtil der var fremkommet en halvfast masse. Derpå fordeltes reaktionsblandingen mellem H20 og ætylæter. Den vandige fase fraskiltes og ekstraheredes derpå med 2 x 400 ml ætylæter.NaBr + Cl- <j: H-OCOOC2H5-> Br-CH-OCOOC2H5 + NaCl 15 CH3 CH3 102.9 g of sodium bromide dissolved in 600 ml of aceotne was reacted for 2-3 hours at room temperature (20-25 ° C) at 152 ° C. 6 g of a-chloro-diethyl carbonate dissolved in 100 ml of acetone. Then, the mixture was concentrated in vacuo at low temperature, at most 35 ° C, until a semi-solid mass was obtained. The reaction mixture was then partitioned between H 2 O and ethyl ether. The aqueous phase was separated and then extracted with 2 x 400 ml ethyl ether.

De forenede organiske faser indeholdende a-bromdiætylkarbo-25 natet vaskedes med først 800 ml H20, derpå med 1000 ml l%s vandig natriummetabisulfatopløsning og derefter 1000 ml mættet opløsning af NaCl.The combined organic phases containing the α-bromo diethyl carbonate were washed with first 800 ml of H 2 O, then with 1000 ml of 1% aqueous sodium metabisulfate solution and then 1000 ml of saturated solution of NaCl.

Den organiske fase tørredes over magniumsulfat og koncentreredes derefter under vakuum ved lav temperatur, højst 30 35°C, til frembringelse af det i overskriften angivne produkt (60%) i form af en væske der oprindelig var farveløs eller svagt gulbrun.The organic phase was dried over magnesium sulfate and then concentrated in vacuo at low temperature, not more than 30 ° C, to give the title product (60%) in the form of a liquid that was initially colorless or slightly yellowish brown.

9 DK 160:·?.° 39 DK 160: ·?. ° 3

Eksempel 2Example 2

En blanding af 44 g (1 mol) acetaldehyd, 300 ml kul-stoftetraklorid og 235 g (1,25 mol) frisk destilleret karbonyl-5 bromid afkøledes til 0°C og holdtes på denne temperatur ved ydre afkøling under tilsætning i løbet af 1 time af 11,9 g (0,15 mol) pyridin.A mixture of 44 g (1 mole) of acetaldehyde, 300 ml of carbon tetrachloride and 235 g (1.25 mole) of freshly distilled carbonyl bromide was cooled to 0 ° C and kept at this temperature by external cooling while adding over 1 hour of 11.9 g (0.15 mol) of pyridine.

Blandingens temperatur fik lov til at stige til omgivelsernes og derpå opvarmedes der til 50°C, på hvilken tempe-10 ratur blandingen holdtes i 3 timer; i løbet af denne periode dannede der sig et bundfald.The temperature of the mixture was allowed to rise to ambient and then heated to 50 ° C, at which temperature the mixture was kept for 3 hours; during this period a precipitate formed.

Inddampning af reaktionsblandingen under nedsat tryk ved 50°C gav en halvfast olieagtig masse som let opløstes i 92 g (2 mol) ætanol ved opvarmning under tilbagesvaling. Ef-1 5 ter opvarmning under tilbagesvaling i yderligere 2 timer fjernedes overskydende ætanol i vakuum og remanensen tritureredes med 100 ml vand og 200 ml metylendiklorid.Evaporation of the reaction mixture under reduced pressure at 50 ° C gave a semi-solid oily mass which was readily dissolved in 92 g (2 moles) of ethanol by reflux heating. After refluxing for an additional 2 hours, excess ethanol was removed in vacuo and the residue was triturated with 100 ml of water and 200 ml of methylene dichloride.

Fraskillelse af det organiske lag og fraktioneret destillation gav 130 g (66% udbytte) rent ætyl-a-bromætylkarbo-20 nat med kogepunkt på 90-92°C/45mm Hg, og forbindelsen var i alle henseender identisk med en autentisk prøve.Separation of the organic layer and fractional distillation gave 130 g (66% yield) of pure ethyl α-bromoethyl carbonate at a boiling point of 90-92 ° C / 45mm Hg, and the compound was identical in all respects to an authentic sample.

Eksempel 3Example 3

En blanding af 44 g (1 mol) acetaldehyd, 300 ml diklor-25 metan og 17,9 g (0,1 mol) hexametylfosforsyretriamid afkøledes til -10°C og der tilsattes gradvis i løbet af 4 timer, i løbet af hvilken periode temperaturen fik lov til at stige til 10°C, 207 g (1,1 mol) frisk destilleret karbonylbromid.A mixture of 44 g (1 mole) of acetaldehyde, 300 ml of dichloromethane and 17.9 g (0.1 mole) of hexamethylphosphoric triamide was cooled to -10 ° C and gradually added over 4 hours, during which period the temperature was allowed to rise to 10 ° C, 207 g (1.1 mole) of freshly distilled carbonyl bromide.

Derefter opvarmedes blandingen under forsigtig tilbage-30 svaling (ca. 40°C) i 4 timer. Mens blandingen stadig var under tilbagesvaling tilsattes der forsigtigt 69 g (1,5 mol) ætanol i løbet af 1 time og opvarmningen under tilbagesvaling fortsattes i yderligere 1 time.Then the mixture was heated under gentle reflux (about 40 ° C) for 4 hours. While the mixture was still under reflux, 69 g (1.5 moles) of ethanol was gently added over 1 hour and the refluxing was continued for an additional 1 hour.

Fraktioneret destillation af den resulterende blanding 35 gav direkte 114 g (58%) rent ætyl-a-bromætylkarbonat.Fractional distillation of the resulting mixture gave directly 114 g (58%) of pure ethyl α-bromomethyl carbonate.

Autenticiteten af det dannede ætyl-α-bromætylkarbonat bekræftedes ved analyse og uafhængig syntese på følgende måde.The authenticity of the ethyl α-bromoethyl carbonate formed was confirmed by analysis and independent synthesis as follows.

1010

DK 1600:.9 BDK 1600: .9 B

118 g (1,0 mol) diætylkarbonat omrørtes og opvarmedes til mellem 110 og 120°C og belystes med en 150 watts wolfram-trådlampe. Der tilsattes dråbevis 96 g (0,6 mol) brom i løbet af en periode på 3-4 timer og med en sådan hastighed at blan-5 dingen ikke blev mørk ud over en lysorange farve. Efter at bromtilsætningen var fuldført afkøledes blandingen til omgivelsernes temperatur og der tilsattes 20 g natriumbikarbonat.118 g (1.0 mole) of diethyl carbonate was stirred and heated to between 110 and 120 ° C and illuminated with a 150 watt tungsten filament lamp. 96 g (0.6 mole) of bromine was added dropwise over a period of 3-4 hours and at such a rate that the mixture did not darken beyond a light orange color. After the bromine addition was complete, the mixture was cooled to ambient temperature and 20 g of sodium bicarbonate was added.

Destillation og fraktionering af den resulterende blanding gav 84,2 g (70%) autentisk ætyl-a-bromætylkarbonat med TO kogepunkt 87-88°C/40 mm Hg.Distillation and fractionation of the resulting mixture yielded 84.2 g (70%) of authentic ethyl α-bromoethyl carbonate with TO boiling point 87-88 ° C / 40 mm Hg.

Eksempel 4Example 4

En blanding af 43 g (0,5 mol) litiumbromid, 15,3 g 15 (0,1 mol) ætyl-a-klorætylkarbonat, 100 ml vand, 100 ml diklor- metan og 1,5 g cetyltrimetylammoniumbromid omrørtes ved omgivelsernes temperatur i 24 timer. Det vandige lag fjernedes og udskiftedes med en frisk opløsning af 26 g (0,3 mol) litiumbromid i 40 ml vand indeholdende 1 g cetyltrimetylammonium-20 bromid. Efter omrøring i yderligere 24 timer, i løbet af hvilken periode temperaturen hævedes til 35°C, fraskiltes det organiske lag, tørredes og vakuumdestilleredes og gav efter gentagen fraktionering den hidtil ukendte forbindelse ætyl-a-brom-ætylkarbonat i en mængde på 15,0 g (76%) med kogepunkt 90-92°C/ 25 35 mm Hg.A mixture of 43 g (0.5 mole) of lithium bromide, 15.3 g of 15 (0.1 mole) of ethyl α-chloroethyl carbonate, 100 ml of water, 100 ml of dichloromethane and 1.5 g of cetyltrimethylammonium bromide was stirred at ambient temperature. 24 hours. The aqueous layer was removed and replaced with a fresh solution of 26 g (0.3 mole) of lithium bromide in 40 ml of water containing 1 g of cetyltrimethylammonium bromide. After stirring for a further 24 hours, during which time the temperature was raised to 35 ° C, the organic layer was separated, dried and vacuum distilled and, after repeated fractionation, gave the novel compound ethyl-α-bromo-ethyl carbonate in an amount of 15.0 g (76%) with boiling point 90-92 ° C / 25 mm Hg.

Beregnet: C 30,5 H 4,6 Br 40,6Calculated: C 30.5 H 4.6 Br 40.6

Fundet: C 30,7 H 4,8 Br 40,1%.Found: C 30.7 H 4.8 Br 40.1%.

NMR-spektret udviste toppe som følger: 1,2-1,6 (3H, triplet? -CH2CH3), 2,0-2,2 (3H, dublet; -CHCH3), 4,1-4,5 (2H, 30 kvartet; -CH2CH3) og 6,5-6,8 (IH, kvartet; -CH.CH3).The NMR spectrum showed peaks as follows: 1.2-1.6 (3H, triplet? -CH2CH3), 2.0-2.2 (3H, doubled; -CHCH3), 4.1-4.5 (2H, 30 quartet; -CH2CH3) and 6.5-6.8 (1H, quartet; -CH.CH3).

Eksempel 5 17,4 g (0,2 mol) litiumbromid opløstes i 150 ml dimetyl-formamid og blandingen afkøledes til omgivelsernes temperatur.Example 5 17.4 g (0.2 mole) of lithium bromide was dissolved in 150 ml of dimethylformamide and the mixture was cooled to ambient temperature.

35 Der tilsattes 30,5 g (0,2 mol) ætyl-a-klorætylkarbonat og blandingen omrørtes ved omgivelsernes temperatur i 24 timer. Det udfældede litiumklorid frafiltreredes og filtratet vakuumde- 1135.5 g (0.2 mole) of ethyl α-chloroethyl carbonate were added and the mixture was stirred at ambient temperature for 24 hours. The precipitated lithium chloride was filtered off and the filtrate vacuum evaporated

DK 1fS0039BDK 1fS0039B

stilleredes så der efter omhyggelig genfraktionering vandtes ætyl-a-bromætylkarbonat i et udbytte på 76%, regnet ud fra genvundet ætyl-a-klorætylkarbonat.Then, after careful re-fractionation, ethyl α-bromoethyl carbonate was recovered in 76% yield, calculated from recovered ethyl α-chloroethyl carbonate.

5 Eksempel 6Example 6

Autenticiteten af den foregående, hidtil ukendte forbindelse ætyl-a-bromætylkarbonat bekræftedes ved uafhængig syntese på følgende måde: 10 En blanding af 35 g (0,3 mol) diætylkarbonat i 50 ml kulstoftetraklorid og 0,1 g α-azoisobutyronitril (AIBN) opvarmedes under forsigtig tilbagesvaling og der tilsattes 28,6 g (0,1 mol) dibromdimetylhydantoin i små portioner i løbet af en periode på 8 timer sammen med yderligere tilsætninger af 15 AIBN (8 x 0,05 g) idet der blev draget omsorg for at sikre at der ikke akkumulerede sig frit brom i reaktionsblandingen.The authenticity of the previous novel compound ethyl a-bromoethyl carbonate was confirmed by independent synthesis as follows: A mixture of 35 g (0.3 mole) of diethyl carbonate in 50 ml of carbon tetrachloride and 0.1 g of α-azoisobutyronitrile (AIBN) was heated. under gentle reflux and 28.6 g (0.1 mole) of dibromo dimethylhydantoin were added in small portions over a period of 8 hours together with further additions of 15 AIBN (8 x 0.05 g), taking care to ensure that no free bromine accumulated in the reaction mixture.

Ved reaktionens slutning underkastedes blandingen fraktioneret vakuumdestillation til frembringelse af 32,3 g (82%) rent ætyl-a-bromætylkarbonat, i alle henseender identisk med pro-20 duktet ifølge eksemplerne 4 og 5.At the end of the reaction, the mixture was subjected to fractional vacuum distillation to give 32.3 g (82%) of pure ethyl α-bromoethyl carbonate, in all respects identical to the product of Examples 4 and 5.

Eksempel 7Example 7

Benzylpenicillin-ætoxykarbonyloxyætylester 25 25,08 g (66,7 mmol) kaliumbenzylpenicillinat, 0,50 g (6,0 mmol) natriumbikarbonat og 2,15 g (6,67 mmol) tetrabutyl-ammoniumbromid omrørtes omhyggeligt i 41 ml metylenklorid og opvarmedes til 40°C. Da denne temperatur var opnået tilsattes der 17,16 g (86,7 mmol) α-bromdiætylkarbonat og opslæmningen 3q omrørtes i 4,0 timer. Der tilsattes 30 ml vand efterfulgt af en mineralsk syre til pH ca. 5. Blandingen omrørtes i ca. 4 timer i løbet af hvilken periode der tilsattes 4%s natrium-hydroxyd for at holde pH mellem 2,5 og 3,0. Derpå tilsattes der 50 ml metylenklorid og blandingen fik lov til at skille 35 sig i nogle få minutter. Den organiske fase vaskedes med 65 ml vand og inddampedes derpå under nedsat tryk. Det herved vundne olieagtige produkt opløstes i 100 ml metylenklorid og inddampedes på ny. Den tilbageværende olie opløstes i metylenklorid til et samlet rumfang på 100 ml.Benzylpenicillin-ethoxycarbonyloxyethyl ester 25.08 g (66.7 mmol) of potassium benzylpenicillinate, 0.50 g (6.0 mmol) of sodium bicarbonate and 2.15 g (6.67 mmol) of tetrabutyl-ammonium bromide was stirred gently in 41 ml of methylene chloride. 40 ° C. When this temperature was reached, 17.16 g (86.7 mmol) of α-bromo diethyl carbonate was added and the slurry 3q was stirred for 4.0 hours. 30 ml of water was added followed by a mineral acid to pH ca. 5. The mixture was stirred for approx. 4 hours during which period 4% of sodium hydroxide was added to maintain the pH between 2.5 and 3.0. Then 50 ml of methylene chloride was added and the mixture was allowed to settle for a few minutes. The organic phase was washed with 65 ml of water and then evaporated under reduced pressure. The oily product thus obtained was dissolved in 100 ml of methylene chloride and evaporated again. The remaining oil was dissolved in methylene chloride to a total volume of 100 ml.

HPLC-analyse af metylenkloridopløsningen viste et ud bytte af benzylpenicillin-ætoxykarbonyloxyætylester på 96-97%.HPLC analysis of the methylene chloride solution showed a yield of 96-97% benzylpenicillin-ethoxycarbonyloxyethyl ester.

12 DK 16Γ039Β12 DK 16Γ039Β

Eksempel 8 5 Benzylpenicillin-ætoxykarbonyloxyætylester 5,02 g (13,3 nurtol) kaliumbenzylpenicillinat og 2,99 g (38,3 mmol) kaliumbikarbonat i 13,5 ml dimetylsulfoxyd omrørtes omhyggeligt i et isbad. I løbet af en periode på 30-40 minutter tilsattes der 3,70 g (18,6 mmol) a-bromdiætylkar-10 bonat under anvendelse af en sprøjtepumpe. Omrøringen fortsattes mens reaktionsblandingen holdtes i isbadet. HPLC-analyse viste at der i løbet af 5-10 minutter var opnået et udbytte på ca. 70% benzylpenicillinætoxykarbonyloxyætylester.Example 8 Benzylpenicillin-ethoxycarbonyloxyethyl ester 5.02 g (13.3 nurtole) of potassium benzylpenicillinate and 2.99 g (38.3 mmol) of potassium bicarbonate in 13.5 ml of dimethyl sulfoxide were stirred carefully in an ice bath. Over a period of 30-40 minutes, 3.70 g (18.6 mmol) of α-bromo diethyl carbonate was added using a syringe pump. Stirring was continued while the reaction mixture was kept in the ice bath. HPLC analysis showed that in 5-10 minutes a yield of approx. 70% benzylpenicillin ethoxycarbonyloxyethyl ester.

15 Eksempel 9Example 9

Benzylpenicillin-ætoxykarbonyloxyætylester 47,03 g (125 mmol) kaliumbenzylpenicillinat, 0,94 g (11 mmol) natriumbikarbonat og 2,01 g (6,25 mmol) tetrabutyl-20 ammoniumbromid omrørtes omhyggeligt i 77 ml acetone og opvarmedes til 40°C. Da denne temperatur var opnået tilsattes der 26,06g (131 mmol) α-bromdiætylkarbonat og opslæmningen omrørtes i 4,5 timer. Der tilsattes 56 ml vand efterfulgt af en mineralsk syre til pH ca. 5. Blandingen omrørtes i ca. 3 ti-25 mer i løbet af hvilken periode der tilsattes 4%s natriumhy- droxyd for at holde pH mellem 4,5 og 4,8. Derpå tilsattes der 100 ml butylacetat og blandingen fik lov til at adskille sig i løbet af nogle få minutter. Den organiske fase vaskedes med 80 ml vand og inddampedes derpå under nedsat tryk. Det til-30 bageværende olieagtige produkt opløstes i metylenklorid til et samlet rumfang på 250 ml. HPLC-analyse af metylenkloridopløsningen viste et udbytte af benzylpenicillin-ætoxykarbonyl-oxyætylester på 98-99%.Benzylpenicillin-ethoxycarbonyloxyethyl ester 47.03 g (125 mmol) of potassium benzylpenicillinate, 0.94 g (11 mmol) of sodium bicarbonate and 2.01 g (6.25 mmol) of tetrabutyl-ammonium bromide was stirred carefully in 77 ml of acetone and heated to 40 ° C. When this temperature was reached, 26.06 g (131 mmol) of α-bromo diethyl carbonate was added and the slurry was stirred for 4.5 hours. 56 ml of water was added followed by a mineral acid to pH ca. 5. The mixture was stirred for approx. 3 hours during which period 4% sodium hydroxide was added to maintain the pH between 4.5 and 4.8. Then 100 ml of butyl acetate was added and the mixture was allowed to separate over a few minutes. The organic phase was washed with 80 ml of water and then evaporated under reduced pressure. The remaining oily product was dissolved in methylene chloride to a total volume of 250 ml. HPLC analysis of the methylene chloride solution showed a yield of benzylpenicillin-ethoxycarbonyl-oxyethyl ester of 98-99%.

Claims (2)

1. Kemisk forbindelse, kendetegnet ved at den er alfa-bromdiætylkarbonat med formlen 5 o Br-CH-O-C-O-C' Hc I ^ 5 ch3Chemical compound, characterized in that it is alpha-bromo diethyl carbonate of the formula 5 O Br-CH-O-C-O-C 'Hc I 2. Anvendelse af alfa-bromdiætylkarbonat som udgangsma-10 teriale ved fremstilling af ætoxykarbonyloxyætylesteren af penicillin G.2. Use of alpha-bromo diethyl carbonate as starting material in the preparation of the ethoxycarbonyloxyethyl ester of penicillin G.
DK296683A 1982-06-29 1983-06-28 THE COMPOUND ALFA-BROMIDAETHYL CARBONATE AND USE OF ALFA-BROMIDAETHYL CARBONATE IN THE PREPARATION OF THE AETOXYCARBONYLOXYAETHYL ESTATE OF PENICILLIN G DK160039C (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
IT22141/82A IT1190897B (en) 1982-06-29 1982-06-29 PROCEDURE FOR THE PREPARATION OF THE 1-ETHOXYCARBONYLOXYETHYL ACID ACID 6- (D (-) - ALPHA AMINOALPHA-PHENYLACETAMIDE) -PENICILLANIC
IT2214182 1982-06-29
GB8226751 1982-09-20
GB8226751 1982-09-20
GB8228622 1982-10-06
GB8228622 1982-10-06
GB8232629 1982-11-16
GB8232629 1982-11-16
GB838300331A GB8300331D0 (en) 1983-01-07 1983-01-07 Preparation of bromo carbonates
GB8300331 1983-01-07

Publications (4)

Publication Number Publication Date
DK296683D0 DK296683D0 (en) 1983-06-28
DK296683A DK296683A (en) 1983-12-30
DK160039B true DK160039B (en) 1991-01-21
DK160039C DK160039C (en) 1991-06-10

Family

ID=27516485

Family Applications (3)

Application Number Title Priority Date Filing Date
DK296683A DK160039C (en) 1982-06-29 1983-06-28 THE COMPOUND ALFA-BROMIDAETHYL CARBONATE AND USE OF ALFA-BROMIDAETHYL CARBONATE IN THE PREPARATION OF THE AETOXYCARBONYLOXYAETHYL ESTATE OF PENICILLIN G
DK105990A DK159821C (en) 1982-06-29 1990-04-30 METHOD FOR PREPARING THE 1-AETOXY CARBONYLOXYA ETHYL ESTER OF 6- (D - (-) - ALFA-AMINO-ALFA-PHENYLACETAMIDO) -PENICILLANIC ACID
DK106090A DK167807B1 (en) 1982-06-29 1990-04-30 METHOD FOR PREPARING THE 1-ETHOXYCARBONYLOXYETHYL ESTER OF 6- (D - (-) - ALFA-AMINO-ALFA-PHENYLACETAMIDO) -PENICILLANIC ACID

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK105990A DK159821C (en) 1982-06-29 1990-04-30 METHOD FOR PREPARING THE 1-AETOXY CARBONYLOXYA ETHYL ESTER OF 6- (D - (-) - ALFA-AMINO-ALFA-PHENYLACETAMIDO) -PENICILLANIC ACID
DK106090A DK167807B1 (en) 1982-06-29 1990-04-30 METHOD FOR PREPARING THE 1-ETHOXYCARBONYLOXYETHYL ESTER OF 6- (D - (-) - ALFA-AMINO-ALFA-PHENYLACETAMIDO) -PENICILLANIC ACID

Country Status (23)

Country Link
JP (2) JPH0819052B2 (en)
AT (1) AT383128B (en)
AU (1) AU566803B2 (en)
BG (3) BG38336A3 (en)
CH (2) CH657620B (en)
CY (2) CY1520A (en)
DD (1) DD211561A5 (en)
DE (2) DE3348299C2 (en)
DK (3) DK160039C (en)
FI (1) FI79115C (en)
FR (1) FR2543957B1 (en)
GB (3) GB2168050A (en)
GR (1) GR78585B (en)
HU (1) HU191534B (en)
IE (1) IE56712B1 (en)
IL (1) IL68992A (en)
IS (1) IS1361B6 (en)
NL (1) NL194081C (en)
NO (3) NO157696C (en)
NZ (1) NZ204736A (en)
PT (1) PT76944B (en)
SE (2) SE454879B (en)
YU (2) YU43926B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573756B1 (en) * 1984-11-23 1987-01-16 Poudres & Explosifs Ste Nale PROCESS FOR THE PREPARATION OF BROMO-1 ETHYL AND HYDROCARBYL CARBONATES AND NOVEL BROMO-1 ETHYL AND HYDROCARBYL CARBONATES

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH516593A (en) * 1967-09-29 1971-12-15 Leo Pharm Prod Ltd Alpha amino-benzyl penicillins - useful as oral antibiotics
US3873521A (en) * 1970-09-17 1975-03-25 Astra Laekemedel Ab Esters of {60 -amino penicillins
IE35648B1 (en) * 1970-09-25 1976-04-14 Beecham Group Ltd Penicillins
DE2161420A1 (en) * 1970-12-30 1972-07-27 Toyama Chemical Co. Ltd., Tokio Penicillin derivatives and processes for their preparation
BE784800A (en) * 1971-06-15 1972-10-02 Yamanouchi Pharma Co Ltd PROCESS FOR PREPARING NEW OXYMETHYL ESTERS OF PENICILLIN AND CEPHALOSPORIN
IL41313A (en) * 1972-02-15 1976-08-31 Harrison Ltd Preparation of the lh-and fsh-releasing hormone and compositions containing it
GB1426869A (en) * 1972-03-13 1976-03-03 Astra Laekemedel Ab Penicillins
GB1425571A (en) * 1972-03-13 1976-02-18 Astra Laekemedel Ab Penicillins and cephaosporins
GB1426717A (en) * 1972-03-13 1976-03-03 Astra Laekemedel Ab Penicillins
SE397981B (en) * 1973-02-19 1977-11-28 Astra Laekemedel Ab NEW TETRAALKYLAMMONIUM SALTS OF 6-AMINOPENICILLANIC ACID AND OF BENZYLPENICILLIN INTENDED TO BE USED AS INTERMEDIATE PRODUCTS IN THE PREPARATION OF CERTAIN ESTERS OF 6-AMINOPENICILLANIC ACID AND OF BENZYLPENIC
GB1565656A (en) * 1975-12-13 1980-04-23 Beecham Group Ltd Preparation of substituted penicillin acid esters
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
JPS5444694A (en) * 1977-09-06 1979-04-09 Kou Kamata Aminobenzylpenicillin derivative
LU84887A1 (en) * 1982-06-30 1984-03-07 Glaxo Group Ltd ANTIBIOTICS OF THE NATURE OF CEPHALOSPORINS AND THEIR PREPARATION PROCESS
EP0108547B1 (en) * 1982-11-04 1989-06-07 Astra Lakemedel Aktiebolag Process for the preparation of the 1'-ethoxycarbonyloxyethyl ester of benzylpenicillin

Also Published As

Publication number Publication date
CH656377A5 (en) 1986-06-30
SE8303414D0 (en) 1983-06-15
FI79115C (en) 1989-11-10
CH657620B (en) 1986-09-15
NL194081C (en) 2001-06-05
DK105990D0 (en) 1990-04-30
JPH0543583A (en) 1993-02-23
SE454879B (en) 1988-06-06
NL194081B (en) 2001-02-01
DK167807B1 (en) 1993-12-20
CY1520A (en) 1990-11-16
DK106090A (en) 1990-04-30
NZ204736A (en) 1986-11-12
YU21886A (en) 1987-10-31
GB2169287B (en) 1987-04-08
BG38336A3 (en) 1985-11-15
YU43693B (en) 1989-10-31
DK159821B (en) 1990-12-10
HU191534B (en) 1987-03-30
AU566803B2 (en) 1987-10-29
SE9100548L (en) 1991-02-26
FI79115B (en) 1989-07-31
AT383128B (en) 1987-05-25
DK105990A (en) 1990-04-30
DK106090D0 (en) 1990-04-30
CY1519A (en) 1990-11-16
JPH0717918A (en) 1995-01-20
NO832351L (en) 1983-12-30
SE503843C2 (en) 1996-09-16
PT76944B (en) 1986-04-09
IS1361B6 (en) 1989-05-25
IE831445L (en) 1983-12-29
JPH0819052B2 (en) 1996-02-28
FI832363L (en) 1983-12-30
GB2168050A (en) 1986-06-11
PT76944A (en) 1983-07-01
GR78585B (en) 1984-09-27
GB2169287A (en) 1986-07-09
DE3348299C2 (en) 1990-12-20
NO851255L (en) 1983-12-30
NO851254L (en) 1983-12-30
DK159821C (en) 1991-04-29
DE3322783A1 (en) 1984-02-09
BG37527A3 (en) 1985-06-14
NL8302286A (en) 1984-01-16
AU1632883A (en) 1984-01-05
GB2168699A (en) 1986-06-25
NO157696C (en) 1988-05-04
FI832363A0 (en) 1983-06-28
YU43926B (en) 1989-12-31
JPH0730082B2 (en) 1995-04-05
YU141583A (en) 1986-06-30
FR2543957B1 (en) 1986-10-24
SE8303414L (en) 1983-12-30
IS2825A7 (en) 1984-07-08
NO157696B (en) 1988-01-25
GB2168699B (en) 1987-04-15
BG38335A3 (en) 1985-11-15
GB8522827D0 (en) 1985-10-23
SE9100548D0 (en) 1991-02-26
IE56712B1 (en) 1991-11-20
DD211561A5 (en) 1984-07-18
ATA238483A (en) 1986-10-15
DK296683D0 (en) 1983-06-28
GB8522826D0 (en) 1985-10-23
DE3322783C2 (en) 1991-01-31
FR2543957A1 (en) 1984-10-12
IL68992A (en) 1991-06-10
GB8528958D0 (en) 1986-01-02
DK160039C (en) 1991-06-10
DK296683A (en) 1983-12-30

Similar Documents

Publication Publication Date Title
EP0270724B1 (en) Preparation of alkyl trifluoroacetoacetate
CN101891693B (en) New method for preparing fluconazole
DK160039B (en) THE COMPOUND ALFA-BROMIDAETHYL CARBONATE AND USE OF ALFA-BROMIDAETHYL CARBONATE IN THE PREPARATION OF THE AETOXYCARBONYLOXYAETHYL ESTATE OF PENICILLIN G
CN111548257B (en) Preparation method of (4-isopropoxy-2-methyl) phenyl isopropyl ketone
JPS5933584B2 (en) Substituted benzylnitrile derivatives
US4606865A (en) Methods for the preparation of α-bromodiethylcarbonate
JP3677786B2 (en) Method for producing aryloxypropionic acid
EP0038052B1 (en) Method for the preparation of cis-alkenyl bromide and acetate
CA1339620C (en) The preparation of an ester of penicilling.
JPS63150249A (en) Production of dialkyl ester 2-vinyl cyclopropane -1, 1-dicarboxylate
KR0156259B1 (en) Preparation of triglycidyl isocyanurate
US6096894A (en) Production method of 2-(p-alkylphenyl)pyridine compound
KR100297802B1 (en) Method for preparing 2- (3-trifluoromethyl) anilinonicotinic acid 2- (N-morpholine) ethyl.
JPH0859605A (en) Synthesis of mercaptocarboxylic ester
US5703248A (en) Process for the selective trihalogenation of ketones useful as intermediates in the synthesis of thiophenes
JPS6254303B2 (en)
CA1295623C (en) Process for the preparation of dialkyl 2- vinylcyclopropane-1,1-dicarboxylates
NO161858B (en) PROCEDURE FOR PREPARING THE 1-ETHOXY CARBONYLOXYETHYL ESTE OF PENICILLIN G.
KR101081115B1 (en) Preparation method of -carotene
EP0403952A2 (en) An environmentally safe method of preparing a certain dialkylamine
EP0038053B1 (en) Method for the preparation of cis-nonen-6-yl chloride
EP0022482B1 (en) Process for preparing 4-hydroxy-3-methyl-2-(2-propynyl)-2-cyclopentenolone; a gamma-diketone compound and substituted acetonedicarboxylic esters
WO2023082149A1 (en) Process and intermediates for preparation of isofetamid
CN104003883A (en) Method for manufacturing high purity tartaric acid dialkyl esters
US20040260119A1 (en) Preparation of 3-alkoxy-2-methylbenzoic acids

Legal Events

Date Code Title Description
PUP Patent expired